On September 24, 2012, Sanofi Pasteur recalled six lots of its injectable typhoid vaccine, Typhim Vi. These lots may have lower antigen content than intended. There are no safety concerns with the vaccine from the recalled lots. At this time, Sanofi Pasteur does NOT recommend revaccination of people who received the recalled vaccine.

The following lots have been recalled:

• Typhim Vi Prefilled syringes
  • E1287-1
  • E1288-1
  • G0481-1
  • G0507-1
  • G0508-1
• Typhim Vi 20-dose vials:
  • G1130-1

All clinics and health care facilities that use Typhim Vi should promptly examine their inventories. Do NOT use any remaining doses from the recalled lots. Instructions for returning product are included in the Recall Notification from Sanofi Pasteur. Typhim Vi vaccine from lots NOT being recalled can be administered.  An alternative vaccine for persons 6 years old and older is VIVOTIF (Typhoid Vaccine Live Oral Ty21a), distributed by Crucell. For more information, contact Sanofi Pasteur at 1-800-872-2463, and see the FDA Recall Announcement.